Growing community of inventors

Rehovot, Israel

Neta Rosenzweig

Average Co-Inventor Count = 3.00

ph-index = 11

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 255

Neta RosenzweigMichal Eisenbach-Schwartz (20 patents)Neta RosenzweigKuti Baruch (20 patents)Neta RosenzweigNeta Rosenzweig (20 patents)Michal Eisenbach-SchwartzMichal Eisenbach-Schwartz (42 patents)Kuti BaruchKuti Baruch (22 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Yeda Research and Develpment & Co. Ltd (20 from 1,168 patents)


20 patents:

1. 11884728 - Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

2. 11884727 - Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

3. 11643464 - Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder

4. 11492405 - Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS

5. 10981989 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

6. 10961309 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

7. 10618963 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

8. 10519237 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

9. 10214585 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

10. 10144778 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

11. 9982047 - Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

12. 9982048 - Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

13. 9982049 - Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease

14. 9982050 - Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease

15. 9982051 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/10/2025
Loading…